9 results
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
Treatment algorithm ... for VTE in Malignancy ... of recurrent VTE ... Anticoagulation #Management ... #Hematology #Oncology
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
Patient risk stratification ... algorithm for the ... treatment of cancer-associated ... Anticoagulation #Management ... #Hematology #Oncology
A quick infographic on various pearls about atopic dermatitis, a disease with an increasing burden on
about possible risk ... factors, management ... #management #medications ... #causes #atopy ... Pedersen MS, Benros
Polycythemia - Differential Diagnosis Algorithm
Polycythemia itself isn’t a diagnosis. Like many things, it is a condition
Differential Diagnosis Algorithm ... circulation = risk ... Better call hematology ... JAK2 V617F) and MPNs ... #workup #hematology
Longterm Venous Thromboembolism Treatment Algorithm
Treat for 3 months and reassess
 • Isolated distal DVT (without cancer)
Thromboembolism Treatment ... Algorithm Treat ... therapy - Second VTE ... #Algorithm #management ... #hematology #anticoagulation
Trigger Finger - Stenosing flexor tendon tenosynovitis

There is a change in the slip between the tendon
flexor tendon tenosynovitis ... diabetes is a risk ... Treatment can be ... #msk #clinical ... #orthopedics #rheumatology
Sjogren's Syndrome Overview

Epidemiology:
• F > M: 9:1
• 5-6th Decades (can be any age)

Autoimmune exocrinopathy multisystemic disease
Nephrogenic DI Hematologic ... phenomenon (16%) MSK ... Adenocarcinoma Treatment ... Sjogrens #Syndrome #Rheumatology ... #Diagnosis #Management
Hemophagocytic Lymphohistiocytosis (HLH) Treatment
Primary HLH:
 - HLH-94 Protocol
    • Dexamethasone
Lymphohistiocytosis (HLH) Treatment ... (depending on CNS ... autoimmune disease, treatment ... spare patient more toxic ... #management #hematology
Essential Thrombocythemia (ET)
ET is a chronic myeloproliferative neoplasm. Most cases are related to mutations that affect
Most cases are related ... • Treatment algorithms ... Thrombocythemia #ET #hematology ... #diagnosis #management ... #hematology